3ET2 | Transcription | date | Oct 06, 2008 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Structure Of Ppardelta With 3-[5-Methoxy-1-(4-Methoxy- Benzenesulfonyl)-1h-Indol-3-Yl]-Propionic Acid | ||||||||||||||
authors | K.Y.J.Zhang, W.Wang | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Peroxisome Proliferator-Activated Receptor Delta Chain: A, B Fragment: Ligand Binding Domain Synonym: Ppar-Delta, Ppar- Beta, Nuclear Receptor Subfamily Member 2, Nuclear Hormone Receptor 1, Nuc1, Nuci; Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Ppard, Nr1c2, Pparb Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Bl21(De3)Ril Expression_system_vector_type: Plasmid Expression_system_plasmid: Pet-28 | ||||||||||||||
symmetry | Space Group: P 1 21 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.24 Å | ||||||||||||
ligand | 1BO, ET1 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent., Artis DR, Lin JJ, Zhang C, Wang W, Mehra U, Perreault M, Erbe D, Krupka HI, England BP, Arnold J, Plotnikov AN, Marimuthu A, Nguyen H, Will S, Signaevsky M, Kral J, Cantwell J, Settachatgull C, Yan DS, Fong D, Oh A, Shi S, Womack P, Powell B, Habets G, West BL, Zhang KY, Milburn MV, Vlasuk GP, Hirth KP, Nolop K, Bollag G, Ibrahim PN, Tobin JF, Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):262-7. Epub 2008 Dec 30. PMID:19116277 |
Data retrieval |
View 3ET2 in 3D |
Visual 3D analysis of 3ET2 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3ET2 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |